Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 15;10(11):2931.
doi: 10.3390/biomedicines10112931.

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer

Affiliations

Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer

Kalhara R Menikdiwela et al. Biomedicines. .

Abstract

Luminal breast cancers are the most common genomic subtype of breast cancers where Luminal A cancers have a better prognosis than Luminal B. Exposure to sex steroids and inflammatory status due to obesity are key contributors of Luminal tumor development. In this study, 1928 patients with Luminal A breast cancer and 1610 patients with Luminal B breast cancer were compared based on body mass index (BMI), age, race, menopausal status, and expressed receptors (i.e., estrogen (ER), progesterone (PR), and human epidermal growth factor receptor 2 (HER2)). Patients with Luminal B tumors had a significantly higher mean BMI (Δ = 0.69 kgm−2 [0.17, 1.21], p = 0.010) versus Luminal A. Interestingly, the risks of Luminal B tumors were higher among Black/African American patients versus White and Hispanic patients (p < 0.001 and p = 0.001, respectively). When controlled for each other, Black/African American race (p < 0.001) and increased BMI (p = 0.008) were associated with increased risks of Luminal B carcinoma, while postmenopausal status was associated with a decreased risk (p = 0.028). Increased BMI partially mediated the strong association between Black/African American race and the risk of Luminal B carcinoma. Thus, Black/African American race along with obesity seem to be associated with an increased risk of more aggressive Luminal B breast carcinomas.

Keywords: Luminal A; Luminal B; breast cancer; obesity; race.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Model diagrams (A,C) and sensitivity plots (B,D) of the mediation analyses examining whether the association between Black/African American race and Luminal B breast carcinoma is mediated by BMI before (A,B) and after (C,D) controlling for the menopausal status. ACME, average causal mediation effect; ADE, average direct effect; a, regression coefficient between Black/African American race and BMI; b, regression coefficient between BMI and Luminal B cancer when controlled for Black/African American race; c, regression coefficient between Black/African American race and Luminal B cancer; c’, regression coefficient between Black/African American race and Luminal B cancer when controlled for BMI; τ, sensitivity parameter required to nullify ACME. Confidence intervals have been obtained using a non-parametric bootstrap approach (1000 simulations). Light colored arrows arising from the covariate Menopause represent the regression coefficients between Menopause and each outcome variable (i.e., BMI and Luminal B cancer) in each model.

Similar articles

Cited by

References

    1. Althuis M.D., Fergenbaum J.H., Garcia-Closas M., Brinton L.A., Madigan M.P., Sherman M.E. Etiology of hormone receptor–defined breast cancer: A systematic review of the literature. Cancer Epidemiol. Prev. Biomark. 2004;13:1558–1568. doi: 10.1158/1055-9965.1558.13.10. - DOI - PubMed
    1. Anastasiadi Z., Lianos G.D., Ignatiadou E., Harissis H.V., Mitsis M. Breast cancer in young women: An overview. Updat. Surg. 2017;69:313–317. doi: 10.1007/s13304-017-0424-1. - DOI - PubMed
    1. Makki J., Myint O., Wynn A.A., Samsudin A.T., Daisy Vanitha J. Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics. Clin. Med. Insights: Pathol. 2015;8:CPath-S19615. doi: 10.4137/CPath.S19615. - DOI - PMC - PubMed
    1. Neuhouser M.L., Aragaki A.K., Prentice R.L., Manson J.E., Chlebowski R., Carty C.L., Ochs-Balcom H.M., Thomson C.A., Caan B.J., Tinker L.F. Overweight, obesity, and postmenopausal invasive breast cancer risk: A secondary analysis of the women’s health initiative randomized clinical trials. JAMA Oncol. 2015;1:611–621. doi: 10.1001/jamaoncol.2015.1546. - DOI - PMC - PubMed
    1. Bhaskaran K., Douglas I., Forbes H., dos-Santos-Silva I., Leon D.A., Smeeth L. Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5· 24 million UK adults. Lancet. 2014;384:755–765. doi: 10.1016/S0140-6736(14)60892-8. - DOI - PMC - PubMed